Cryosite Ltd
Company Profile
Business description
Cryosite Ltd provides specialised, temperature-controlled logistics and depot services, including secure storage, labelling, secondary packaging, import/export coordination, inventory management, distribution, destruction and reverse logistics. The Group supports Good Manufacturing Practice clinical trial products, Australian Register of Therapeutic Goods approved medicines, biologics, Advanced Therapy Medicinal Products, Research and Development materials and medical devices. Its segments are Ambient, Cold and Frozen, Ultra-frozen and Cryogenic, and Cord Blood. The Ambient, Cold and Frozen segment generates maximum revenue and provides storage and distribution of small-molecule drugs and related products requiring ambient, refrigerated or frozen conditions.
Contact
13a Ferndell Street
South Granville
SydneyNSW2142
AUST: +61 288652000
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
Employees
27
Stocks News & Analysis
stocks
Tesla: Shares fall as market disappointed with Cybercab launch event
stocks
The best global tech stocks to buy
stocks
Earnings margins to improve for mining specialist
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,098.40 | 20.20 | -0.22% |
| CAC 40 | 8,317.98 | 11.83 | 0.14% |
| DAX 40 | 26,007.63 | 1.10 | 0.00% |
| Dow JONES (US) | 52,786.07 | 628.18 | -1.18% |
| FTSE 100 | 10,811.66 | 10.47 | -0.10% |
| HKSE | 25,317.18 | 95.94 | -0.38% |
| NASDAQ | 26,421.41 | 85.58 | -0.32% |
| Nikkei 225 | 65,504.25 | 234.92 | 0.36% |
| NZX 50 Index | 13,786.38 | 6.52 | -0.05% |
| S&P 500 | 7,673.52 | 45.08 | -0.58% |
| S&P/ASX 200 | 8,906.60 | 21.00 | -0.24% |
| SSE Composite Index | 3,940.55 | 7.85 | 0.20% |